PriceTargets.com logo

Calyxt - CLXT Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.30 As of 05/31/2023 01:00 AM ET
+0 (0.00%)
Get New Calyxt Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLXT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLXT

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Calyxt in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $6.30.

This chart shows the closing price for CLXT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Calyxt. This rating has held steady since October 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/17/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/15/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/14/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/8/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/4/2022HC WainwrightDowngradeBuy ➝ Neutral
3/4/2022Canaccord Genuity GroupLower TargetBuy$300.00 ➝ $200.00
11/2/2021Roth CapitalInitiated CoverageBuy$500.00
12/15/2020Berenberg BankInitiated CoverageBuy$450.00
12/10/2020HC WainwrightInitiated CoverageBuy$500.00
8/13/2020National SecuritiesDowngradeBuy ➝ Neutral
5/15/2020Wells Fargo & CompanyLower TargetEqual Weight$300.00 ➝ $200.00
5/8/2020National SecuritiesReiterated RatingBuy$500.00
5/8/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$650.00 ➝ $350.00
3/23/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
3/6/2020National SecuritiesReiterated RatingBuy$800.00
3/6/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$750.00 ➝ $300.00
3/5/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$950.00 ➝ $350.00
2/10/2020National SecuritiesReiterated RatingBuy$800.00
12/23/2019National SecuritiesReiterated RatingBuy$800.00
(Data available from 12/8/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/12/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/11/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/11/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/10/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/9/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/9/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/8/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/8/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Calyxt logo
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.
Read More

Today's Range

Now: $6.30
Low: $6.01
High: $7.77

50 Day Range

MA: $13.58
Low: $6.30
High: $31.50

52 Week Range

Now: $6.30
Low: $1.25
High: $7.77

Volume

254,056 shs

Average Volume

139,308 shs

Market Capitalization

$31.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.98

Frequently Asked Questions

What sell-side analysts currently cover shares of Calyxt?

The following sell-side analysts have issued reports on Calyxt in the last twelve months:
View the latest analyst ratings for CLXT.

What is the current price target for Calyxt?

0 Wall Street analysts have set twelve-month price targets for Calyxt in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Calyxt in the next year.
View the latest price targets for CLXT.

What is the current consensus analyst rating for Calyxt?

Calyxt currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CLXT.

What other companies compete with Calyxt?

Other companies that are similar to Calyxt include LianBio, ANEW Medical, PHAXIAM Therapeutics, 9 Meters Biopharma and PolarityTE. Learn More about companies similar to Calyxt.

How do I contact Calyxt's investor relations team?

Calyxt's physical mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company's listed phone number is (651) 683-2807 and its investor relations email address is [email protected]. The official website for Calyxt is www.calyxt.com. Learn More about contacing Calyxt investor relations.